Navigation Links
SemBioSys announces senior management changes
Date:1/12/2009

r SemBioSys," said Andrew Baum, president and chief executive officer of Botaneco.

About SemBioSys

Calgary, Alberta-based SemBioSys is a biotechnology company developing protein-based pharmaceuticals using its proprietary protein production technology. This technology enables the production of therapeutic proteins in plant seeds by genetically enhancing the safflower plant. SemBioSys' lead pharmaceutical candidates are recombinant human insulin, which is intended to serve the rapidly expanding global diabetes market, and Apo AIMilano. Apo AIMilano is a variant of Apo AI, the major protein associated with high density lipoprotein (HDL), or "good cholesterol", whose function is to remove excess cholesterol from arteries. In addition to its pharmaceutical products, SemBioSys' subsidiary, Botaneco Specialty Ingredients Inc., is selling oleosome-based all natural products in the global personal care ingredient market. More information is available and can be accessed at www.sembiosys.com.

About Botaneco Specialty Ingredients Inc.

Botaneco is the global developer and marketer of innovative oleosome-based ingredients to the personal care and OTC topical markets. As a technologically driven provider of high performance, proprietary oleosome-based ingredients, Botaneco is committed to developing innovative ingredients that offer multifunctional, tangible and documented benefits to both formulators and consumers. Botaneco's head office and manufacturing facility is located in Calgary, Canada and its satellite office in Bensalem, PA. More information is available and can be accessed at www.botaneco.ca.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "antici
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
2. SemBioSys begins phase I/II trial of insulin produced in plant seeds
3. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
4. SemBioSys announces second quarter 2008 financial and operational results
5. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
6. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
7. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
8. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
9. SemBioSys announces first quarter 2008 financial and operational results
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys initiates toxicology study for safflower-produced insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... a teleconference to discuss its First Quarter 2013 financial ... information is provided below: Date: Thursday, May ... Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 ( ... For those unable to participate in the ...
(Date:5/23/2013)... 2013 During the conduct of ... adhere to principles of good clinical practice (GCP) ... Dr. Jeremy Lim, Fellow, Clinical Development at Novartis ... ,     Understand the International Conference on Harmonization (ICH) ... regulations for the conduction of clinical trials , ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 Bed bugs ... against the pests is still ongoing, a report from kmov.com ... more for the bed bug treatment. Meanwhile, to be of ... apartment from the costly bed bug exterminator service. ... stated that AHA has so far spent $35,000 ...
Breaking Biology Technology:Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
... Conference kicked off today with a high level ... traveled to Scottsdale for this event which is serving ... new consumer and enterprise technology products. , ,The ... venture capitalists, and veteran technologists who come to see ...
... Care International, Inc. announced Tuesday Herbert Conrad as chairman of ... remain on the board of directors. , , ... Division of Hoffmann-La Roche, Inc. He served as the chairman ... to 2003, and was a co-founder of Reliant Pharmaceuticals in ...
... La Crosse, Wis. -- Firstlogic Inc. , ... Oracle Corp. approved technology from Firstlogics Information ... , ,Oracle Warehouse Builder is a business intelligence ... software allows users to design their business intelligence ...
Cached Biology Technology:Entrepreneurs Preview Liberating Technologies 2Entrepreneurs Preview Liberating Technologies 3
(Date:5/23/2013)... palsy with autologous cord blood. Following a cardiac arrest ... had been in a persistent vegetative state with ... with the cord blood containing stem cells, the symptoms ... to speak simple sentences and to move. "Our findings, ... long-held doubts about the effectiveness of the new therapy", ...
(Date:5/23/2013)... microbial pathogens are growing increasingly resistant to the conventional ... Wisconsin scientists has synthesized a potent new class of ... infections. , Writing online in the Journal of ... University of Wisconsin-Madison chemistry Professor Helen Blackwell describes agents ... Staphylococcus aureus , a bacterium at the root ...
(Date:5/22/2013)... novel technique that can detect molecular variants in chemical ... of the most important, though time-consuming, processes in analytical ... Nature , post-doctoral researcher David Patterson, Professor of ... Center for Free-Electron Laser Science (CFEL) in Hamburg, Germany ... to identify molecular variants apart, and to determine how ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2University of Wisconsin chemists find new compounds to curb staph infection 2Detecting mirror molecules 2Detecting mirror molecules 3
... Johns Hopkins report using a laser beam to activate a ... like a school of fish turning in social unison, following ... The study of this unexpected cell movement, reported May ... for understanding embryonic development, wound healing and tumor metastasis ...
... having trouble getting a date, French researchers suggest that ... were more prepared to give their number to an ... according to research that appears today in the journal ... There,s plenty of research indicating that the media affects ...
... researchers from the University of Santiago de Compostela (USC) ... behaviour. The results show that the principal goal of ... home. The most antisocial among them place greater importance ... place most importance on are to do with leaving ...
Cached Biology News:Fly cells flock together, follow the light 2Fly cells flock together, follow the light 3Love ballad leaves women more open to a date 2Teenagers want to finish their studies and leave home 2
Purified Mouse anti-Hu Actopaxin (pS8) Storage Temperature: Refrigerate(2 to 8C)...
... (Lys 4) Immunogen: ... Ac K]Q... in which [ Ac K] ... histone H3 Accession Number: ... Mr ~17kDa Quality ...
... FastPlax Antibody is used to detect the ... surface of infected cells as early as ... of the FastPlax Titer Kit, which allows ... hours. The FastPlax Antibody can ...
Anti-Mouse Ly 6C.2 , Ascites (Clone 5075-3.6) (mouse IgG2b)...
Biology Products: